|

HHV8 and Solid Organ Transplantation

RECRUITINGSponsored by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Actively Recruiting
SponsorFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Started2021-09-15
Est. completion2024-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05081141

Summary

Solid organ transplant candidates will undergo serological screening for HHV8 at time of listing and transplantation. In the event of a recipient/donor mismatch R-/D+ or in the presence of a seropositive recipient (R+), blood levels of HHV8 DNA will be monitored together with specific IGRA for HHV8.

Eligibility

Age: 18 Years+Healthy volunteers accepted
SOT DONORS:

Inclusion Criteria:

* all donors used for transplantation purposes (kidney, liver, lung), including living donors in case of kidney transplantation

Exclusion Criteria:

* None

SOT CANDIDATES RECIPIENTS:

Inclusion Criteria:

* All patients listed for solid organ transplantation (lung, liver and kidney)

Exclusion Criteria:

* None

Conditions12

CancerCastleman DiseaseHHV8HHV8 InfectionHHV8-Related Malignant NeoplasmKaposi SarcomaKidney Transplant; ComplicationsLiver CancerLiver DiseaseLiver Transplant; Complications

Browse More Trials

Cancer trialsLung Cancer trialsLiver Disease trialsLiver Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.